Stay updated on Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial page.

Latest updates to the Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page shows a site revision update to v3.4.2 and removal of a prior government-funding status notice (v3.4.1). These changes are maintenance-related and do not alter the displayed study details or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedA site-wide notice about a lapse in government funding has been added, stating information may not be up to date and the NIH Clinical Center is open, with links to cc.nih.gov and opm.gov. The page's revision tag updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedAdded UI element: Show glossary, and new metadata items: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed older items: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision label updated to v3.3.4; the previous v3.3.3 label has been removed.SummaryDifference0.1%

- Check63 days agoChange DetectedLocations for Ontario and Saskatchewan were added and the HHS Vulnerability Disclosure link removed; page revision updated to v3.3.3.SummaryDifference0.3%

- Check92 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; this appears to be a backend version update with no impact on study content, eligibility criteria, outcomes, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial page.